Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73601 - 73625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	VEGFA	7422	upregulated	Silicon Dioxide analog results in increased expression of VEGFA mRNA	6p21.1	A24195
Silicon dioxide	Approved	VEGFA	7422	downregulated	Silicon Dioxide results in decreased expression of VEGFA mRNA	6p21.1	A24196
Silicon dioxide	Approved	VEGFC	7424	downregulated	Silicon Dioxide analog results in decreased expression of VEGFC mRNA	4q34.3	A24194
Silicon dioxide	Approved	VEGFC	7424	upregulated	Silicon Dioxide analog results in increased expression of VEGFC mRNA	4q34.3	A24195
Silicon dioxide	Approved	VEPH1	79674	downregulated	Silicon Dioxide analog results in decreased expression of VEPH1 mRNA	3q25.31-q25.32	A24195
Silicon dioxide	Approved	VGLL1	51442	upregulated	Silicon Dioxide results in increased expression of VGLL1 mRNA	Xq26.3	A24196
Silicon dioxide	Approved	VGLL3	389136	downregulated	Silicon Dioxide analog results in decreased expression of VGLL3 mRNA	3p12.1	A24195
Silicon dioxide	Approved	VHL	7428	downregulated	Silicon Dioxide analog results in decreased expression of VHL mRNA	3p25.3	A24194
Silicon dioxide	Approved	VIL1	7429	downregulated	Silicon Dioxide analog results in decreased expression of VIL1 mRNA	2q35	A24195
Silicon dioxide	Approved	VIL1	7429	upregulated	Silicon Dioxide analog results in increased expression of VIL1 mRNA	2q35	A24194
Silicon dioxide	Approved	VILL	50853	downregulated	Silicon Dioxide analog results in decreased expression of VILL mRNA	3p22.2	A24195
Silicon dioxide	Approved	VIPR1	7433	upregulated	Silicon Dioxide analog results in increased expression of VIPR1 mRNA	3p22.1	A24195
Silicon dioxide	Approved	VIPR1	7433	downregulated	Silicon Dioxide results in decreased expression of VIPR1 mRNA	3p22.1	A24196
Silicon dioxide	Approved	VIT	5212	downregulated	Silicon Dioxide analog results in decreased expression of VIT mRNA	2p22.2	A24195
Silicon dioxide	Approved	VIT	5212	upregulated	Silicon Dioxide analog results in increased expression of VIT mRNA	2p22.2	A24194
Silicon dioxide	Approved	VLDLR-AS1	401491	downregulated	Silicon Dioxide analog results in decreased expression of VLDLR-AS1 mRNA	9p24.2	A24194
Silicon dioxide	Approved	VMO1	284013	downregulated	Silicon Dioxide analog results in decreased expression of VMO1 mRNA	17p13.2	A24195
Silicon dioxide	Approved	VNN2	8875	upregulated	Silicon Dioxide analog results in increased expression of VNN2 mRNA	6q23.2	A24195
Silicon dioxide	Approved	VPS13D	55187	downregulated	Silicon Dioxide analog results in decreased expression of VPS13D mRNA	1p36.22-p36.21	A24195
Silicon dioxide	Approved	VPS18	57617	upregulated	Silicon Dioxide analog results in increased expression of VPS18 mRNA	15q15.1	A24195
Silicon dioxide	Approved	VPS9D1	9605	downregulated	Silicon Dioxide analog results in decreased expression of VPS9D1 mRNA	16q24.3	A24195
Silicon dioxide	Approved	VSIG1	340547	downregulated	Silicon Dioxide analog results in decreased expression of VSIG1 mRNA	Xq22.3	A24195
Silicon dioxide	Approved	VSNL1	7447	downregulated	Silicon Dioxide results in decreased expression of VSNL1 mRNA	2p24.2	A24196
Silicon dioxide	Approved	VSTM2L	128434	downregulated	Silicon Dioxide analog results in decreased expression of VSTM2L mRNA	20q11.23	A24195
Silicon dioxide	Approved	VSTM4	196740	downregulated	Silicon Dioxide analog results in decreased expression of VSTM4 mRNA	10q11.23	A24194

Displaying entries 73601 - 73625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability